Pulmonary arterial hypertension, or PAH, is a rare and severe disease characterized by elevated blood pressure in the ...

Clinical worsening also occurred less frequently with treprostinil ...

Venous thromboembolism includes deep vein thrombosis (DVT) and pulmonary embolism, which have incidence rates of between 1 and 2 cases per 1000 people for the first episode.1,2 Strong, provoking risk ...

Pulmonary involvement is highly prevalent in individuals with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), affecting 82.7% of patients with granulomatosis with polyangiitis ...

Older patients with PAH who were at least 55 years old showed significantly smaller improvements in 6-minute walk distance.

During the winter months, when days are short and cold and nights are long and dark, creating a warm and cozy indoor atmosphere can feel especially important.

BACKGROUND: Right ventricular failure drives both morbidity and mortality in pulmonary arterial hypertension (PAH), but the mechanism of transition from compensated right ventricle (cRV) to ...

Background Pulmonary fibrosis (PF) caused by interstitial lung diseases (ILDs) affects up to 0.1% of the global population. There is growing global interest in PF, evident from a nearly threefold ...

You will be redirected to our submission process. In the era of big data, the growing diversity, dimensionality, and volume of data have accelerated the development of artificial intelligence (AI). In ...

Prostacyclin analogues for pulmonary arterial hypertension may reduce the risk for developing nonproliferative diabetic retinopathy.

Ultrafine particles are of particular concern from a health perspective. They are easily inhaled into our lungs, but research has found they are excreted from the body very slowly.